Adiponectin affects vascular smooth muscle cell proliferation and apoptosis through modulation of the mitofusin-2-mediated Ras-Raf-Erk1/2 signaling pathway

Zhang,Wenbo; Shu,Chang; Li,Quanming; Li,Ming; Li,Xin

doi:10.3892/mmr.2015.3899

Adiponectin affects vascular smooth muscle cell proliferation and apoptosis through modulation of the mitofusin-2-mediated Ras-Raf-Erk1/2 signaling pathway

Authors:
- Wenbo Zhang
- Chang Shu
- Quanming Li
- Ming Li
- Xin Li
View Affiliations

Affiliations: Department of Vascular Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, P.R. China
Published online on: June 8, 2015 https://doi.org/10.3892/mmr.2015.3899
Pages: 4703-4707

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Vascular smooth muscle cells (VSMCs) undergo cell biological changes in response to a variety of cytokines and growth factors. Adiponectin inhibits neointimal formation through suppressing the proliferation and migration of VSMCs. However, the mechanisms underlying the effect of adiponectin on VSMC proliferation and apoptosis require further investigation. The present study was designed to investigate the mechanisms of adiponectin on VSMC proliferation and apoptosis, focusing on the mitofusin‑2 (MFN2) mediated Ras‑Raf‑extracellular signal regulated kinase (Erk)1/2 signaling pathway. The results of western blot analysis revealed that adiponectin increased the expression of MFN2 in a concentration‑dependent manner. Adiponectin also suppressed VSMC proliferation and induced VSMC apoptosis. However, transfection of the VSMCs with small interfering (si)RNA, to knock down the expression of MFN2 attenuated the effect of adiponectin on VSMC proliferation and apoptosis. The decreased expression levels of Ras, phosphorlated (p)‑c‑Raf and p‑Erk1/2, observed in the VSMCs treated with adiponectin were also reversed by the transfection of the VSMCs with MFN2 siRNA to knock down the expression of MFN2. The results of the present study demonstrated for the first time, to the best of our knowledge, that adiponectin exhibits an inhibitory effect on VSMC proliferation and induces cell proliferation via regulation of the expression levels of MFN2. Adiponectin upregulated the expression of MFN2, inhibiting the Ras‑Raf‑Erk1/2 signaling pathway, which led to the inhibition of VSMC proliferation and the induction of VSMC apoptosis. The results of the present study may provide a novel basis for the therapy of vascular disease.

View Figures

View References

1	Kiyan Y, Limbourg A, Kiyan R, et al: Urokinase receptor associates with myocardin to control vascular smooth muscle cells phenotype in vascular disease. Arterioscler Thromb Vasc Biol. 32:110–122. 2012. View Article : Google Scholar
2	Matsuzawa Y, Funahashi T and Nakamura T: Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann N Y Acad Sci. 892:146–154. 1999. View Article : Google Scholar
3	Henry BA and Clarke IJ: Adipose tissue hormones and the regulation of food intake. J Neuroendocrinol. 20:842–849. 2008. View Article : Google Scholar : PubMed/NCBI
4	Yamauchi T, Kamon J, Waki H, et al: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 7:941–946. 2001. View Article : Google Scholar : PubMed/NCBI
5	Berg AH, Combs TP, Du X, Brownlee M and Scherer PE: The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med. 7:947–953. 2001. View Article : Google Scholar : PubMed/NCBI
6	Maeda N, Shimomura I, Kishida K, et al: Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med. 8:731–737. 2002. View Article : Google Scholar : PubMed/NCBI
7	Matsuzawa Y: Establishment of a concept of visceral fat syndrome and discovery of adiponectin. Proc Jpn Acad Ser B Phys Biol Sci. 86:131–141. 2010. View Article : Google Scholar : PubMed/NCBI
8	Wulster-Radcliffe MC, Ajuwon KM, Wang J, Christian JA and Spurlock ME: Adiponectin differentially regulates cytokines in porcine macrophages. Biochem Biophys Res Commun. 316:924–929. 2004. View Article : Google Scholar : PubMed/NCBI
9	Matsuda M, Shimomura I, Sata M, et al: Role of adiponectin in preventing vascular stenosis The missing link of adipo-vascular axis. J Biol Chem. 277:37487–37491. 2002. View Article : Google Scholar : PubMed/NCBI
10	Chen H, Montagnani M, Funahashi T, Shimomura I and Quon MJ: Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem. 278:45021–45026. 2003. View Article : Google Scholar : PubMed/NCBI
11	Maeda N, Shimomura I, Kishida K, et al: Dietinduced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med. 8:731–737. 2002. View Article : Google Scholar : PubMed/NCBI
12	Ding M, Carrão AC, Wagner RJ, et al: Vascular smooth muscle cell-derived adiponectin: a paracrine regulator of contractile phenotype. J Mol Cell Cardiol. 52:474–484. 2012. View Article : Google Scholar :
13	Matsuda M, Shimomura I, Sata M, et al: Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem. 277:37487–37491. 2002. View Article : Google Scholar : PubMed/NCBI
14	Wang Y, Lam KS, Xu JY, Lu G, Xu LY, Cooper GJ and Xu A: Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. J Biol Chem. 280:18341–18347. 2005. View Article : Google Scholar : PubMed/NCBI
15	Motobayashi Y, Izawa-Ishizawa Y, Ishizawa K, et al: Adiponectin inhibits insulin-like growth factor-1-induced cell migration by the suppression of extracellular signal-regulated kinase 1/2 activation, but not Akt in vascular smooth muscle cells. Hypertens Res. 32:188–193. 2009. View Article : Google Scholar : PubMed/NCBI
16	Takaoka M, Nagata D, Kihara S, et al: Periadventitial adipose tissue plays a critical role in vascular remodeling. Circ Res. 105:906–911. 2009. View Article : Google Scholar : PubMed/NCBI
17	Miao CY and Li ZY: The role of perivascular adipose tissue in vascular smooth muscle cell growth. Br J Pharmacol. 165:643–658. 2012. View Article : Google Scholar :
18	Nepal S and Park PH: Regulatory role of autophagy in globular adiponectin-induced apoptosis in cancer cells. Biomol Ther (Seoul). 22:384–389. 2014. View Article : Google Scholar
19	Yamauchi T, Kamon J, Ito Y, et al: Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature. 423:762–769. 2003. View Article : Google Scholar : PubMed/NCBI
20	Hug C, Wang J, Ahmad NS, Bogan JS, Tsao TS and Lodish HF: T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc Natl Acad Sci USA. 101:10308–10313. 2004. View Article : Google Scholar : PubMed/NCBI
21	Zhou L, Deepa SS, Etzler JC, et al: Adiponectin activates AMP-activated protein kinase in muscle cells via APPL1/LKB1-dependent and phospholipase C/Ca2+/Ca2+/calmodulin-dependent protein kinase kinase-dependent pathways. J Biol Chem. 284:22426–22435. 2009. View Article : Google Scholar : PubMed/NCBI
22	Iwabu M, Yamauchi T, Okada-Iwabu M, et al: Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca (2+) and AMPK/SIRT1. Nature. 464:1313–1319. 2010. View Article : Google Scholar : PubMed/NCBI
23	Santel A and Fuller MT: Control of mitochondrial morphology by a human mitofusin. J Cell Sci. 114:867–874. 2001.PubMed/NCBI
24	Chen KH, Guo X, Ma D, et al: Dysregulation of HSG triggers vascular proliferative disorders. Nat Cell Biol. 6:872–883. 2004. View Article : Google Scholar : PubMed/NCBI
25	Jin B, Fu G, Pan H, et al: Anti-tumour efficacy of mitofusin-2 in urinary bladder carcinoma. Med Oncol. 28(Suppl 1): 373–380. 2011. View Article : Google Scholar
26	Wu L, Li Z, Zhang Y, et al: Adenovirus-expressed human hyper-plasia suppressor gene induces apoptosis in cancer cells. Mol Cancer Ther. 7:222–232. 2008. View Article : Google Scholar : PubMed/NCBI
27	Wang W, Zhu F, Wang S, et al: HSG provides antitumor efficacy on hepatocellular carcinoma both in vitro and in vivo. Oncol Rep. 24:183–188. 2010.PubMed/NCBI
28	Wang W, Lu J, Zhu F, et al: Pro-apoptotic and anti-proliferative effects of mitofusin-2 via Bax signaling in hepatocellular carcinoma cells. Med Oncol. 29:70–76. 2010. View Article : Google Scholar : PubMed/NCBI
29	Chen KH, Dasgupta A, Ding J, Indig FE, Ghosh P and Longo DL: Role of mitofusin 2 (Mfn2) in controlling cellular proliferation. FASEB J. 28:382–394. 2014. View Article : Google Scholar :
30	Zhang GE, Jin HL, Lin XK, Chen C, Liu XS, Zhang Q and Yu JR: Anti-tumor effects of mfn2 in gastric cancer. Int J Mol Sci. 14:13005–13021. 2013. View Article : Google Scholar : PubMed/NCBI
31	Ortmann J, Veit M, Zingg S, et al: Estrogen receptor-α but not-β or GPER inhibits high glucose-induced human VSMC proliferation: potential role of ROS and ERK. J Clin Endocrinol Metab. 96:220–228. 2011. View Article : Google Scholar :
32	Sirois MG, Simons M and Edelman ER: Antisense oligonucleotide inhibition of PDGFR-beta receptor subunit expression directs suppression of intimal thickening. Circulation. 95:669–676. 1997. View Article : Google Scholar : PubMed/NCBI